Clinical and Translational Neuroscience: Time for a Change: “What’s Past Is Prologue” ^†

The first issue of Clinical and Translational Neuroscience (CTN) (ISSN: 2514-183X) appeared in 2017 [1,2]. The new journal was the successor of the Swiss Archives of Neurology and Psychiatry (SANP) which was founded by Constantin von Monakow in 1917 to overcome the difficulties to publish abroad during the first World War and to improve the communication between the German and the French speaking regions of Switzerland. A hundred years later, a new journal was again born to foster communication and interaction, this time between clinical and basic neuroscience, an inter- and transdisciplinarity which is essential but difficult in medicine [3].

The first four years have been a success, confirming the interest and potential of CTN. Contributions about current hot topics and the future of neurology, neurosurgery, neuroradiology, psychiatry, neuroscience, neurohumanities, etc., appeared back-to-back in CTN. In addition, articles from the Headache Center in Munich, the Memory Center in Lausanne and the Vertigo Center in Zurich illustrate the interest and the practical realization of diverse centers crossing disciplines and institutional structures. Potentials, pitfalls, and challenges in translating basic research into clinical practice have been exemplified in articles devoted to sleep, stroke, and ataxia research topics. New sections have been created thanks to the initiative of the young neuroscientists of the Swiss Federation of Clinical Neuro-Societies (SFCNS) [4], as well as by colleagues interested in the history of neuroscience and those particularly valuing single cases studies.

The COVID-19 pandemic has dramatically changed our lives, challenged the resilience of our health systems while demonstrating more effective ways to conduct, share, and communicate science [5]. Following the first four successful years and the very professional and fruitful cooperation with SAGE, the Board of CTN and the SFCNS have decided to change publishers so as to foster a faster and more robust review and production of the articles while also enhancing the international inclusiveness and impact of the journal.

I thank our readers, authors, reviewers and friends for their support in transforming the original idea into the current reality of CTN. A special thank goes to Mrs. Maya Ringli for her dedication and outstanding commitment as the first scientific manager of CTN.

Please join the CTN family in embracing these changes and demonstrating values in its mission to provide neuroscientists with outstanding articles that enhance patient care, education, and professionalism.